-
1
-
-
0003998061
-
-
Philadelphia, PA, Lippincott, Williams and Wilkins
-
DeVita VJ, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice. Philadelphia, PA, Lippincott, Williams and Wilkins, 2001
-
(2001)
Cancer: Principles and Practice
-
-
DeVita, V.J.1
Hellman, S.2
Rosenberg, S.A.3
-
2
-
-
0018240239
-
Germ cell tumors(II): VAB II in metastatic testicular cancer
-
Cheng E, Cvitkovic E, Wittes RE, et al: Germ cell tumors(II): VAB II in metastatic testicular cancer. Cancer 42:2162-2168, 1978
-
(1978)
Cancer
, vol.42
, pp. 2162-2168
-
-
Cheng, E.1
Cvitkovic, E.2
Wittes, R.E.3
-
3
-
-
0017672542
-
Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer
-
Einhorn LH, Donohue J: Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293-298, 1977
-
(1977)
Ann Intern Med
, vol.87
, pp. 293-298
-
-
Einhorn, L.H.1
Donohue, J.2
-
4
-
-
0019418649
-
VAB-3 combination chemotherapy of metastatic testicular cancer
-
Reynolds TF, Vugrin D, Cvitkovic E, et al: VAB-3 combination chemotherapy of metastatic testicular cancer. Cancer 48:888-898, 1981
-
(1981)
Cancer
, vol.48
, pp. 888-898
-
-
Reynolds, T.F.1
Vugrin, D.2
Cvitkovic, E.3
-
5
-
-
0019513021
-
Adjuvant chemotherapy combination of vinblastine, actinomycin D, bleomycin, and chlorambucil following retroperitoneal lymph node dissection for stage II testis tumor
-
Vugrin D, Whitmore WF, Cvitkovic E, et al: Adjuvant chemotherapy combination of vinblastine, actinomycin D, bleomycin, and chlorambucil following retroperitoneal lymph node dissection for stage II testis tumor. Cancer 47:840-844, 1981
-
(1981)
Cancer
, vol.47
, pp. 840-844
-
-
Vugrin, D.1
Whitmore, W.F.2
Cvitkovic, E.3
-
6
-
-
0027513298
-
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: A multi-institutional study
-
Bajorin DF, Sarosdy MF, Pfister DG, et al: Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: A multi-institutional study. J Clin Oncol 11:598-606, 1993
-
(1993)
J Clin Oncol
, vol.11
, pp. 598-606
-
-
Bajorin, D.F.1
Sarosdy, M.F.2
Pfister, D.G.3
-
7
-
-
0023684525
-
A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors
-
Bosl GJ, Geller NL, Bajorin D, et al: A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. J Clin Oncol 6:1231-1238, 1988
-
(1988)
J Clin Oncol
, vol.6
, pp. 1231-1238
-
-
Bosl, G.J.1
Geller, N.L.2
Bajorin, D.3
-
8
-
-
0024555713
-
Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: A Southeastern Cancer Study Group protocol
-
Einhorn LH, Williams SD, Lochrer PJ, et al: Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: A Southeastern Cancer Study Group protocol. J Clin Oncol 7:387-391, 1989
-
(1989)
J Clin Oncol
, vol.7
, pp. 387-391
-
-
Einhorn, L.H.1
Williams, S.D.2
Lochrer, P.J.3
-
9
-
-
0028860147
-
Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: An Eastern Cooperative Oncology Group trial
-
Loehrer PJ Sr, Johnson D, Elson P, et al: Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: An Eastern Cooperative Oncology Group trial. J Clin Oncol 13:470-476, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 470-476
-
-
Loehrer P.J., Sr.1
Johnson, D.2
Elson, P.3
-
10
-
-
0030757467
-
Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin
-
Xiao H, Mazumdar M, Bajorin DF, et al: Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin. J Clin Oncol 15:2553-2558, 1997
-
(1997)
J Clin Oncol
, vol.15
, pp. 2553-2558
-
-
Xiao, H.1
Mazumdar, M.2
Bajorin, D.F.3
-
11
-
-
0018258188
-
Improved management of nonseminomatous testis tumors
-
Donohue JP, Einhorn LH, Perez JM: Improved management of nonseminomatous testis tumors. Cancer 42:2903-2908, 1978
-
(1978)
Cancer
, vol.42
, pp. 2903-2908
-
-
Donohue, J.P.1
Einhorn, L.H.2
Perez, J.M.3
-
12
-
-
0031892019
-
Clinical stage I nonseminoma: Surgery versus surveillance
-
Foster RS, Roth BJ: Clinical stage I nonseminoma: Surgery versus surveillance. Semin Oncol 25:145-153, 1998
-
(1998)
Semin Oncol
, vol.25
, pp. 145-153
-
-
Foster, R.S.1
Roth, B.J.2
-
13
-
-
0017143127
-
Prognosis for pathologic stage I non-seminomatous germ cell tumors of the testis managed by retroperitoneal lymphadenectomy
-
Johnson DE, Bracken RB, Blight EM: Prognosis for pathologic stage I non-seminomatous germ cell tumors of the testis managed by retroperitoneal lymphadenectomy. J Urol 116:63-65, 1976
-
(1976)
J Urol
, vol.116
, pp. 63-65
-
-
Johnson, D.E.1
Bracken, R.B.2
Blight, E.M.3
-
14
-
-
0020567662
-
Selected experience with surgery and combination chemotherapy in the treatment of nonseminomatous testis tumors
-
Bredael JJ, Vugrin D, Whitmore WF Jr: Selected experience with surgery and combination chemotherapy in the treatment of nonseminomatous testis tumors. J Urol 129:985-988, 1983
-
(1983)
J Urol
, vol.129
, pp. 985-988
-
-
Bredael, J.J.1
Vugrin, D.2
Whitmore W.F., Jr.3
-
15
-
-
0018875735
-
Testicular cancer: Risk factors and the role of adjuvant chemotherapy
-
Jacobs EM, Muggia FM: Testicular cancer: Risk factors and the role of adjuvant chemotherapy. Cancer 45:1782-1790, 1980
-
(1980)
Cancer
, vol.45
, pp. 1782-1790
-
-
Jacobs, E.M.1
Muggia, F.M.2
-
16
-
-
0021084037
-
Stage II nonseminomatous testicular cancer: A 10-year experience
-
Vogelzang NJ, Fraley EE, Lange PH, et al: Stage II nonseminomatous testicular cancer: A 10-year experience. J Clin Oncol 1:171-178, 1983
-
(1983)
J Clin Oncol
, vol.1
, pp. 171-178
-
-
Vogelzang, N.J.1
Fraley, E.E.2
Lange, P.H.3
-
17
-
-
0019433694
-
Adjuvant chemotherapy with VAB-3 of stage II-B testicular cancer
-
Vugrin D, Whitmore W, Cvitkovic E, et al: Adjuvant chemotherapy with VAB-3 of stage II-B testicular cancer. Cancer 48:233-237, 1981
-
(1981)
Cancer
, vol.48
, pp. 233-237
-
-
Vugrin, D.1
Whitmore, W.2
Cvitkovic, E.3
-
18
-
-
0019464095
-
VAB-4 combination chemotherapy in the treatment of metastatic testis tumors
-
Vugrin D, Cvitkovic E, Whitmore WF Jr, et al: VAB-4 combination chemotherapy in the treatment of metastatic testis tumors. Cancer 47:833-839, 1981
-
(1981)
Cancer
, vol.47
, pp. 833-839
-
-
Vugrin, D.1
Cvitkovic, E.2
Whitmore W.F., Jr.3
-
19
-
-
0020659795
-
VAB-6 combination chemotherapy in resected stage II-B testis cancer
-
Vugrin D, Whitmore WF Jr, Herr HW, et al: VAB-6 combination chemotherapy in resected stage II-B testis cancer. Cancer 51:5-8, 1983
-
(1983)
Cancer
, vol.51
, pp. 5-8
-
-
Vugrin, D.1
Whitmore W.F., Jr.2
Herr, H.W.3
-
20
-
-
0026318099
-
Adjuvant chemotherapy of metastatic stage II nonseminomatous testis tumor
-
Weissbach L, Hartlapp JH: Adjuvant chemotherapy of metastatic stage II nonseminomatous testis tumor. J Urol 146:1295-1298, 1991
-
(1991)
J Urol
, vol.146
, pp. 1295-1298
-
-
Weissbach, L.1
Hartlapp, J.H.2
-
21
-
-
0025902314
-
Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer?
-
Richie JP, Kantoff PW: Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer? J Clin Oncol 9:1393-1396, 1991
-
(1991)
J Clin Oncol
, vol.9
, pp. 1393-1396
-
-
Richie, J.P.1
Kantoff, P.W.2
-
22
-
-
0018852516
-
Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: Current perspective
-
Skinner DG, Scardino PT: Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: Current perspective. J Urol 123:378-382, 1980
-
(1980)
J Urol
, vol.123
, pp. 378-382
-
-
Skinner, D.G.1
Scardino, P.T.2
-
23
-
-
0023243140
-
Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer
-
Williams SD, Stablein DM, Einhorn LH, et al: Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 317:1433-1438, 1987
-
(1987)
N Engl J Med
, vol.317
, pp. 1433-1438
-
-
Williams, S.D.1
Stablein, D.M.2
Einhorn, L.H.3
-
24
-
-
0020470226
-
Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cisplatinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer
-
Vugrin D, Whitmore WF Jr, Herr H, et al: Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cisplatinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer. J Urol 128:715-717, 1982
-
(1982)
J Urol
, vol.128
, pp. 715-717
-
-
Vugrin, D.1
Whitmore W.F., Jr.2
Herr, H.3
-
25
-
-
0023258435
-
Adjuvant chemotherapy in nonseminomatous testicular tumour stage II
-
Hartlapp JH, Weissbach L, Bussar-Maatz R: Adjuvant chemotherapy in nonseminomatous testicular tumour stage II. Int J Androl 10:277-284, 1987
-
(1987)
Int J Androl
, vol.10
, pp. 277-284
-
-
Hartlapp, J.H.1
Weissbach, L.2
Bussar-Maatz, R.3
-
26
-
-
0021142733
-
No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis
-
Pizzocaro G, Monfardini S: No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis. J Urol 131:677-680, 1984
-
(1984)
J Urol
, vol.131
, pp. 677-680
-
-
Pizzocaro, G.1
Monfardini, S.2
-
27
-
-
0021863878
-
Surgical treatment of patients with stages I and II nonseminomatous testicular cancer
-
Fraley EE, Narayan P, Vogelzang NJ, et al: Surgical treatment of patients with stages I and II nonseminomatous testicular cancer. J Urol 134:70-73, 1985
-
(1985)
J Urol
, vol.134
, pp. 70-73
-
-
Fraley, E.E.1
Narayan, P.2
Vogelzang, N.J.3
-
28
-
-
0026057869
-
Two-drug therapy in patients with metastatic germ cell tumors
-
Bajorin DF, Geller NL, Weisen SF, et al: Two-drug therapy in patients with metastatic germ cell tumors. Cancer 67:28-32, 1991
-
(1991)
Cancer
, vol.67
, pp. 28-32
-
-
Bajorin, D.F.1
Geller, N.L.2
Weisen, S.F.3
-
29
-
-
0023195303
-
Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide
-
Williams SD, Birch R, Einhorn LH, et al: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316:1435-1440, 1987
-
(1987)
N Engl J Med
, vol.316
, pp. 1435-1440
-
-
Williams, S.D.1
Birch, R.2
Einhorn, L.H.3
-
30
-
-
0028783356
-
Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors
-
Motzer RJ, Sheinfeld J, Mazumdar M, et al: Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors. J Clin Oncol 13:2700-2704, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 2700-2704
-
-
Motzer, R.J.1
Sheinfeld, J.2
Mazumdar, M.3
-
31
-
-
0021347523
-
Adjuvant chemotherapy in resected stage-II nonseminomatous germ cell tumors of testis. In which cases is it necessary?
-
Pizzocaro G, Piva L, Salvioni R, et al: Adjuvant chemotherapy in resected stage-II nonseminomatous germ cell tumors of testis. In which cases is it necessary? Eur Urol 10:151-158, 1984
-
(1984)
Eur Urol
, vol.10
, pp. 151-158
-
-
Pizzocaro, G.1
Piva, L.2
Salvioni, R.3
-
32
-
-
0034012705
-
Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. The Indiana University experience
-
Behnia M, Foster R, Einhorn LH, et al: Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. The Indiana University experience. Eur J Cancer 36:472-475, 2000
-
(2000)
Eur J Cancer
, vol.36
, pp. 472-475
-
-
Behnia, M.1
Foster, R.2
Einhorn, L.H.3
-
33
-
-
0035300616
-
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: Pattern and prognostic factors for relapse
-
Rabbani F, Sheinfeld J, Farivar-Mohseni H, et al: Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: Pattern and prognostic factors for relapse. J Clin Oncol 19:2020-2025, 2001
-
(2001)
J Clin Oncol
, vol.19
, pp. 2020-2025
-
-
Rabbani, F.1
Sheinfeld, J.2
Farivar-Mohseni, H.3
|